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Abstract
Objective: To evaluate ovarian response and cumulative live birth rate of women undergoing in-vitro fertilization (IVF)
treatment who had discordant baseline serum anti-Mullerian hormone (AMH) level and antral follicle count (AFC).
Methods: This is a retrospective cohort study on 1,046 women undergoing the first IVF cycle in Queen Mary Hospital, Hong
Kong. Subjects receiving standard IVF treatment with the GnRH agonist long protocol were classified according to their
quartiles of baseline AMH and AFC measurements after GnRH agonist down-regulation and before commencing ovarian
stimulation. The number of retrieved oocytes, ovarian sensitivity index (OSI) and cumulative live-birth rate for each
classification category were compared.
Results: Among our studied subjects, 32.2% were discordant in their AMH and AFC quartiles. Among them, those having
higher AMH within the same AFC quartile had higher number of retrieved oocytes and cumulative live-birth rate. Subjects
discordant in AMH and AFC had intermediate OSI which differed significantly compared to those concordant in AMH and
AFC on either end. OSI of those discordant in AMH and AFC did not differ significantly whether either AMH or AFC quartile
was higher than the other.
Conclusions: When AMH and AFC are discordant, the ovarian responsiveness is intermediate between that when both are
concordant on either end. Women having higher AMH within the same AFC quartile had higher number of retrieved
oocytes and cumulative live-birth rate.
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Introduction
Ovarian response markers, such as serum follicle stimulating
hormone (FSH) concentration, antral follicle count (AFC) and
serum anti-Mullerian hormone (AMH) concentration are often
employed in in vitro fertilisation (IVF) programmes to predict
ovarian response to gonadotrophin stimulation [1,2]. Systematic
reviews showed that among the common ovarian response
markers, AFC and AMH had the best and comparable
performance in predicting both poor and excessive ovarian
responses [3,4,5]. Nonetheless, the prediction of pregnancy
outcomes by these markers is poor [4,6,7]. Hence, the clinical
applications of these markers are mainly in prognostic counseling
as well as in individualization of the stimulation regimen.
AMH, also known as Mullerian-inhibiting substance, is a
dimeric glycoprotein hormone which is a member of the
transforming growth factor-beta family. In adult women, AMH
is exclusively produced by granulosa cells of preantral and small
antral follicles, and has been shown to have excellent correlation
with the primordial follicle pool [8]. Hence, AMH may reflect
ovarian reserve as well.
AMH and AFC have been shown to have a very good
correlation with each other, although AFC may be more machine-
and operator-dependent and could have higher inter-operator
variability compared to AMH. Yet, discordance between AMH
and AFC does occur in some individual women. To our
knowledge, there have been no reported data on the implications
of ovarian response and success rate in women undergoing IVF
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treatment who had discordant AMH and AFC. On the other
hand, studies have revealed considerably high frequency of
discordance between AMH and FSH in women undergoing IVF
[9,10]. Therefore, we conducted this retrospective analysis to
evaluate the discordance frequency between AMH and AFC in
women undergoing IVF treatment, and its implication on the
ovarian response and the cumulative live birth outcome.
Materials and Methods
Subject selection
This retrospective review included all first IVF cycles carried out
between January 2007 and December 2009 at the Centre of
Assisted Reproduction and Embryology, The University of Hong
Kong – Queen Mary Hospital, Hong Kong, excluding those
involving the use of donor oocytes, blastocyst transfer and/or pre-
implantation genetic diagnosis. Only the first treatment cycle of
each subject in our Centre was included for this study, regardless
of whether the subjects had previous IVF treatment elsewhere.
Those with blastocyst transfer and/or pre-implantation genetic
diagnosis were not included in this study because the extended
embryo culture would have altered the total number of replaceable
embryos and hence the cumulative live birth outcome. A similar
cohort of subjects has been used in another study recently
published by our group [7], to which details can be referred. Only
subjects treated on the long GnRH agonist protocol were selected
for the current study. Ethics approval was obtained from the
Institutional Review Board of the University of Hong Kong/
Hospital Authority Hong Kong West Cluster for this retrospective
study to be carried out using existing patient data in an
anonymous manner, waiving the requirement for written consent
from individual patients.
Stimulation cycle, AFC and AMH determination, and
frozen-thawed embryo transfer
Details of the stimulation cycle have been reported previously
[7]. In the long GnRH agonist protocol, the subject received
buserelin (Suprecur, Hoechst, Frankfurt, Germany) nasal spray
starting from the mid-luteal phase of the cycle preceding the
stimulation cycle. In the early follicular phase of the treatment
cycle after return of period, transvaginal ultrasound scan was
performed using a 5 MHz vaginal probe (Voluson 730, GE
Healthcare, Wisconsin, USA) to count the total number of antral
follicles ranging from 2 to 9 mm. All ultrasound scans were
performed by reproductive medicine specialists who had at least 7
years of experience in gynaecological ultrasound and had been
trained under the same supervisor. Blood was taken for routine
estradiol measurement, and the residual serum samples were
archived at 220uC. For the current study, these stored serum
samples were retrieved for AMH measurement using the AMH
Gen II ELISA kit (Beckman Coulter, Webster, TX, USA;
catalogue number A79765). The assay kit has a sensitivity of
0.08 ng/ml, and intra- and inter-assay coefficients of variation of
less than 5.4 and 5.6%.
After confirming a basal serum estradiol level, the subjects
received human menopausal gonadotrophin (HMG) or recombi-
nant FSH for ovarian stimulation. They continued the buserelin
nasal spray till human chorionic gonadotrophin (hCG) trigger.
The initial dose of gonadotrophin stimulation was decided based
on the baseline AFC (AFC$15: 150 IU per day; AFC between 6
and 14: 300 IU for the first two days followed by 150 IU daily;
AFC#5: 300–450 IU for the first two days followed by 225 IU
daily). hCG (Pregnyl 5000 or 10000 units or Ovidrel 250 mg) was
given to trigger final oocyte maturation when there were at least 3
follicles reaching 16 mm or above in mean diameter, with the
leading one reaching 18 mm. Transvaginal ultrasound-guided
oocyte retrieval was carried out 36 hours later. In-vitro fertilisation
was performed either by conventional insemination or intracyto-
plasmic sperm injection (ICSI) depending on semen parameters.
Embryo replacement was carried out two days after fertilization. A
maximum of two embryos were allowed per transfer.
Surplus embryos of grades 1 to 4 [11,12] were cryopreserved on
the day of the embryo transfer. Frozen-thawed embryo transfers
were carried out in natural cycles for ovulatory women, and in
clomiphene-induced cycles or hormone replacement cycles for
anovulatory women. Details of the embryo cryopreservation and
frozen-thawed embryo transfer protocols have been previously
described [12].
Grouping of subjects according to upper and lower
quartiles of AMH and AFC
Using data of all the 1,152 women undergoing the first IVF
cycle during the study period, the 25th percentile and 75th
percentile values of serum AMH concentration were 1.4 ng/ml
and 5.3 ng/ml respectively, whereas those of AFC were 6 and 14
respectively. Our subjects were then grouped according to whether
their AMH and AFC values were in the lower quartile, upper
quartile or in between (Table 1).
Statistical analysis
The primary outcome measures were the number of oocytes
retrieved, ovarian sensitivity index (OSI= number of retrieved
oocytes per 1,000 IU of gonadotrophin (FSH) administered) [13],
and the cumulative live birth in the fresh plus all frozen-thawed
embryo transfers following the same index stimulation cycle. Non-
normally distributed continuous variables were expressed as
median (interquartile range) unless otherwise stated. Continuous
and categorical variables were compared between groups using
Mann-Whitney test or Kruskal-Wallis test with Conover post-hoc
analysis, and Fisher’s Exact test respectively. Statistical analysis
was carried out using the IBM SPSS Statistics (Version 20, IBM
Corporation, U.S.A.) and MedCalc (Version 12.5, MedCalc
Software, Belgium). The two-tailed value of P,0.05 was
considered statistically significant.
Results
There were 1,152 women undergoing the first IVF treatment
cycle during the study period, out of which we studied on 1,046
subjects who fulfilled the inclusion criteria and being treated on
the long GnRH agonist protocol. The clinical and demographic
parameters of the included subjects are listed in Table S1.
Discordance between AMH and AFC
As shown in Table 1, subjects in Groups 1, 5 and 9, i.e. 709 out
of 1046 (67.8%), were concordant in AMH and AFC. This means
that the rest 337 subjects (32.2%) showed discordance between
AMH and AFC. There was no significant difference (p.0.05) in
body mass index among the groups.
Number of retrieved oocytes as stratified by subject
grouping
Comparing the groups within the same AFC category, i.e. 1 vs
4, 2 vs 5 vs 8 and 6 vs 9, the groups with higher AMH levels had
significantly higher numbers of oocytes retrieved (Table 2).
AMH and AFC Discordance
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Cumulative live birth rate as stratified by subject
grouping
Group 4 had a significantly higher cumulative live birth rate
compared to group 1. Likewise, the cumulative live birth rate was
significantly higher in group 8 than in group 5, which was in turn
higher than in group 2. Similarly, group 9 had significantly higher
cumulative live birth rate compared to group 6 (Table 3).
OSI as stratified by subject grouping
Among groups 1, 2, 4 and 5, the OSI of groups 2 and 4 (i.e. the
discordant groups) was significantly lower than that of group 1 and
higher than that of group 5 (p,0.05 for both comparisons).
Likewise, the OSI of groups 6 and 8 (i.e. the discordant groups)
was significantly lower than that of group 5 but higher than that of
group 9 (p,0.05 for both comparisons). There was no significant
difference in OSI between groups 2 and 4, and between groups 6
and 8 (p.0.05) (Table 4).
Discussion
Many studies have consistently reported that AMH and AFC
were among the best ovarian response markers for prediction of
ovarian response in IVF treatment, and that their performance
was probably comparable [4,5,7]. Strong significant correlations
between AMH and AFC have also been demonstrated. This is
explainable by the fact that AMH is produced from granulosa cells
of small antral follicles. However, to our knowledge, there has
been no report on the incidence or implication of discordance in
AMH and AFC in these subjects. On the other hand, there have
been some reports on discordance between AMH and FSH, the
more conventional ovarian reserve marker, in women undergoing
IVF [9,10]. To decide what best to be done when the two markers
give discordant results is a real practical issue.
We studied ovarian response in terms of the number of retrieved
oocytes as well as OSI. OSI, which refers to the number of oocytes
retrieved per 1000 IU gonadotrophin administered, is a measure
of ovarian responsiveness. A strong correlation of OSI with the
number of retrieved oocytes and other measures of ovarian
response has been demonstrated by our group [13]. The use of this
ratio in our study eliminates the confounding effect of the different
initial doses of gonadotrophin being used across the different
subject groups based on baseline AFC; this allows more
appropriate comparison of ovarian response between groups.
Our results showed that a significant proportion, amounting to
more than 30%, of subjects undergoing IVF treatment were
discordant in AMH and AFC as classified by their quartiles. The
discordant groups with low to normal ovarian reserve had ovarian
responsiveness intermediate between those with concordantly low
and concordantly normal AMH and AFC. Likewise the discordant
groups with normal to high ovarian reserve had ovarian
responsiveness intermediate between those with concordantly
normal and concordantly high AMH and AFC. Within each
AFC category, those with higher AMH had significantly higher
number of oocytes retrieved and OSI. This finding was compatible
with our current understanding from most available studies. As
AMH is chiefly secreted from ovarian granulosa cells in the adult
Table 1. Grouping of subjects according to the quartile of serum AMH and AFC values.
Serum AMH (ng/ml) Antral follicle count (AFC)
,6 6–14 .14 Total
,1.4 Group 1 Group 2 Group 3 (207)
(128) (78) (1)
1.4–5.3 Group 4 Group 5 Group 6 (555)
(70) (395) (90)
.5.3 Group 7 Group 8 Group 9 (284)
(4) (94) (186)
Total (202) (567) (277) (1046)
The number of subjects in each group is indicated in brackets.
doi:10.1371/journal.pone.0108493.t001
Table 2. Number of retrieved oocytes in different subject groups classified according to the quartile of serum AMH and AFC.
Serum AMH (ng/ml) Antral follicle count (AFC)
,6 6–14 .14
,1.4 Group 1 Group 2 Group 3
4 (3–7)a 6 (4–8)b 15‘
1.4–5.3 Group 4 Group 5 Group 6
8 (6–10)a 9 (6–11)b,c 10 (7–15)d
.5.3 Group 7 Group 8 Group 9
12.5 (10–16) 12 (9–16)c 14 (11–18)d
Values are expressed in median (interquartile range).
a,b,c,d p,0.0001 (statistically significant. Mann-Whitney U test).
‘Only 1 case.
doi:10.1371/journal.pone.0108493.t002
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women, it serves as an index of the follicular pool size [8] which
directly determines ovarian response.
We also studied the implication on the cumulative live birth rate
when subjects in the same AFC category, hence subjected to the
same stimulation regimen, were in different AMH categories. In
such circumstances, those with discordantly higher AMH category
generally had significantly higher cumulative live birth rates. Since
the cumulative live birth is mainly determined by the total number
of transferrable embryos from the same index stimulation cycle
[7], which is in turn dependent on the number of oocytes
retrieved, it is not surprising that the implications of the
discordance between AMH and AFC on the cumulative live birth
mirrored that on ovarian responsiveness on the whole.
Likewise, when comparing groups within the same AMH
category, those having higher AFC did have higher OSI, as shown
in Table 4. However, we could not analyse the number of oocytes
and cumulative live birth rate in this manner as in our protocol
there was inherent variation of stimulation dose based on AFC.
The reason of the discordance between AMH and AFC is not
absolutely certain. It may be due to the fact that the serum AMH
level is not exactly reflecting the population of antral follicles
counted in our AFC measurement, i.e. those between 2 to 9 mm
in size. It has been suggested that the peak production of AMH
occurs in small antral follicles up to 8 mm [14], beyond which it
starts to drop. Another study showed that AMH concentration in
follicular fluid dropped with follicular size from 3 mm to 9 mm,
and reached negligible level when the follicle grew beyond 10 mm
[15]. In other words, what we counted in the AFC measurement
might not all be producing the same amount of AMH
concurrently. On the other hand, not all the preantral and small
antral follicles contributing to the AMH measured would
subsequently develop to maturity leading to oocyte being yielded.
Moreover, there could be intra- and inter-operator variability of
AFC measurement, as well as intra- and inter-assay variability of
AMH measurement, which may contribute to discordance in some
cases.
In this study, we classified the AMH and AFC measurements as
low and high based on their respective lower and upper quartiles.
The cut-offs of 6 and 14 for AFC actually were compatible with
those suggested by previous studies for poor and excessive
responders [16,17]. The cut-offs for AMH adopted in this study
was slightly higher numerically compared to most previous studies
[16,17], which actually varied across a wide range mainly because
of different AMH assay methods used. In this study, AMH was
measured by the Beckman-Coulter Gen II ELISA kit, which was
Table 3. Cumulative live birth rate in different subject groups classified according to the quartile of serum AMH and AFC.
Serum AMH (ng/ml) Antral follicle count (AFC)
,6 6–14 .14
,1.4 Group 1 Group 2 Group 3
40/112 (35.7%)a 24/61 (39.3%)b 1/1 (100.0%)
1.4–5.3 Group 4 Group 5 Group 6
36/65 (55.4%)a 206/372 (55.4%)b,c 48/85 (56.5%)d
.5.3 Group 7 Group 8 Group 9
1/1 (100.0%) 63/86 (73.3%)c 114/164 (69.5%)d
Values are expressed in median (interquartile range).
a p = 0.012 (statistically significant, Fisher’s Exact test).
b p = 0.026 (statistically significant, Fisher’s Exact test).
c p = 0.002 (statistically significant, Fisher’s Exact test).
d p = 0.0497 (statistically significant, Fisher’s Exact test).
doi:10.1371/journal.pone.0108493.t003
Table 4. Ovarian sensitivity index in different subject groups classified according to the quartile of serum AMH and AFC.
Serum AMH (ng/ml) Antral follicle count (AFC)
,6 6–14 .14
,1.4 Group 1 Group 2 Group 3
1.3 (0.8–2.1)a,b,c 2.2. (1.4–3.3)a,d 10.0‘
1.4–5.3 Group 4 Group 5 Group 6
2.4 (2.1–3.6)b,e 3.8 (2.4–5.5)c,d,e,f,g,h 6.5 (3.7–8.2)f,i
.5.3 Group 7 Group 8 Group 9
5.8 (4.3–6.5) 6.5 (4.7–9.3)g,j 8.8 (5.9–12.6)h,i,j
Values are expressed in median (interquartile range).
‘Only 1 case.
Comparison I (between Groups 1, 2, 4 and 5):
a,b,c,d,ep,0.05 (Kruskal-Wallis test with Conover post-hoc analysis).
Comparison II (between Groups 5, 6, 8 and 9):
f,g,h,i,jp,0.05 (Kruskal-Wallis test with Conover post-hoc analysis).
doi:10.1371/journal.pone.0108493.t004
AMH and AFC Discordance
PLOS ONE | www.plosone.org 4 October 2014 | Volume 9 | Issue 10 | e108493
introduced relatively recently. This is the current one in the
market, but was not what most previous reports were based on.
The current study only included those treated on the long
GnRH agonist protocol so as to avoid the potential confounding
effect of different protocols on the outcome measures. As over 90%
of our subjects were treated on the long GnRH agonist protocol
during the studied period, this gave a fair representation of the
overall patient cohort. Repeating the analyses after inclusion of
those treated on the GnRH antagonist protocol gave the same
conclusion (data not shown). Only the first treatment cycle of each
subject in our centre was included in this analysis so as to avoid
bias arising from over-representation of subjects receiving multiple
treatment cycles during the study period. Although some subjects
had received previous IVF treatment elsewhere, this should not
have affected the conclusion drawn in this study. The AMH and
AFC were measured at commencement of ovarian stimulation
after pituitary down-regulation. Our group has previously shown
that AFC is not significantly altered by short-term GnRH agonist
treatment for pituitary down-regulation [18]. Our own cohort also
showed that GnRH agonist down-regulation did not significantly
alter serum AMH measurement compared to pre-down-regulation
level (unpublished data); it has also been reported that AMH
measurement at the start of ovarian stimulation in IVF patients
down-regulated with GnRH agonist still had good prediction of
ovarian response [19].
In all, our results suggested that when AMH and AFC are
discordant, those having higher AMH within the same AFC
quartile had higher number of retrieved oocytes and cumulative
live birth rate, and the ovarian responsiveness is intermediate
between that when both are concordant on either end. Both AMH
and AFC would be recommended to be utilized for individual-
ization of stimulation regimen; when the AMH and AFC fall into
discordant categories, it would be sensible to adopt an interme-
diate dose of gonadotrophin as compared to those with concordant
AMH and AFC categories on either end. Such theoretical
consideration, however, is yet to be proven in further clinical
trials which are keenly awaited.
Supporting Information
Table S1 Clinical and demographic parameters of the
subjects included in this study.
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